Evan A Stein
LIB Therapeutics · LIB Therapeutics LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Evan A Stein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:48 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05004675 · Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD PatientsLIB Therapeutics LLC · completed · Hypercholesterolemia, Atherosclerotic Ischemic Disease · study director
- Ph3NCT04806893 · Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C ReductionLIB Therapeutics LLC · unknown · Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke · study director
- Ph3NCT04797247 · Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C ReductionLIB Therapeutics LLC · unknown · Cardiovascular Diseases, Hyper-LDL-cholesterolemia · study director
- Ph3NCT04790513 · Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD PatientsLIB Therapeutics LLC · completed · Hypercholesterolemia, Cardiovascular Diseases · study director
- Ph3NCT04034485 · Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFHLIB Therapeutics LLC · completed · Homozygous Familial Hypercholesterolemia · study director
- Ph2NCT03847974 · Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003LIB Therapeutics LLC · completed · Hypercholesterolemia · study director
- Ph2NCT03549260 · Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C ReductionLIB Therapeutics LLC · completed · LDL Cholesterol · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 11 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:48 UTC. The ranking covers the 200 most relevant of 108 PubMed records, and a shared surname and initials can bring in a namesake. All 108 on PubMed
- 4,160 citationsRCR 113.2
- 1,277 citationsRCR 42.4
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).Am J Cardiol · 20031,096 citationsRCR 27.1
- Simvastatin with or without ezetimibe in familial hypercholesterolemia.N Engl J Med · 2008956 citationsRCR 24.7
- 631 citationsRCR 22.1
- 614 citationsRCR 21.3
- A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.N Engl J Med · 2014600 citationsRCR 17.7
- Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.N Engl J Med · 2012559 citationsRCR 14.0
- 482 citationsRCR 12.7
- 443 citationsRCR 10.4